Novartis AG ADR sell Barclays PLC
Start price
22.02.25
/
50%
€103.50
Target price
22.02.26
-
Performance (%)
32.85%
End price
23.02.26
€137.50
Summary
This prediction ended on 23.02.26 with a price of €137.50. The SELL prediction by Barclays_PLC for Novartis AG ADR was trending in the completely wrong direction and closed with a performance of 32.85%. A total of €3.87 was paid as dividends for this prediction. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novartis AG ADR | 3.759% | 3.759% | 28.372% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Barclays_PLC for this prediction
In the thread Novartis AG ADR diskutieren
Novartis AG (NYSE: NVS) had its "underweight" rating re-affirmed by analysts at Barclays PLC.
Ratings data for NVS provided by MarketBeat
In the thread Trading Novartis AG ADR
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten